Search research articles
Contact Us
Filters
Showing results (21-30 of 114) with videos related to
Page
of 12
Sort By:
Antimicrobial Agents and Chemotherapy
|
September 25, 2003
Fluoroquinolone-containing third-line regimen against Mycobacterium tuberculosis in vivo
Nicolas Veziris, Chantal Truffot-Pernot, Alexandra Aubry, et al.
Journal of Clinical Microbiology
|
October 6, 2006
Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance
Florence Brossier, Nicolas Veziris, Chantal Truffot-Pernot, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 11, 2009
Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis
Murad Ibrahim, Chantal Truffot-Pernot, Koen Andries, et al.
BMC Infectious Diseases
|
January 14, 2014
Rifampicin mono-resistant tuberculosis in France: a 2005-2010 retrospective cohort analysis
Vanina Meyssonnier, Thuy Van Bui, Nicolas Veziris, et al.
The Journal of Antimicrobial Chemotherapy
|
September 9, 2016
In vivo Mycobacterium tuberculosis fluoroquinolone resistance emergence: a complex phenomenon poorly detected by current diagnostic tests
Christine Bernard, Alexandra Aubry, Aurélie Chauffour, et al.
Plos Neglected Tropical Diseases
|
September 1, 2020
Telacebec (Q203)-containing intermittent oral regimens sterilized mice infected with Mycobacterium ulcerans after only 16 doses
Aurélie Chauffour, Jérôme Robert, Nicolas Veziris, et al.
BMC Infectious Diseases
|
November 18, 2021
Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study
Nicolas Veziris, Claire Andréjak, Stéphane Bouée, et al.
Plos Neglected Tropical Diseases
|
November 27, 2023
Minimal effective dose of bedaquiline administered orally and activity of a long acting formulation of bedaquiline in the murine model of leprosy
Aurélie Chauffour, Nacer Lounis, Koen Andries, et al.
Journal of Clinical Microbiology
|
July 10, 2015
Characterization of a Clone of Mycobacterium tuberculosis Clinical Isolates with Mutations in KatG (A110V), EthA (Q269STOP), and the inhA Promoter (-15C→T)
Florence Brossier, Christophe Sola, Christine Bernard, et al.
Journal of Clinical Microbiology
|
October 3, 2014
Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare
Aurélie Renvoisé, Christine Bernard, Nicolas Veziris, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 114) with videos related to
Sort By:
Page
of 12
Antimicrobial Agents and Chemotherapy
|
September 25, 2003
Fluoroquinolone-containing third-line regimen against Mycobacterium tuberculosis in vivo
Nicolas Veziris, Chantal Truffot-Pernot, Alexandra Aubry, et al.
Journal of Clinical Microbiology
|
October 6, 2006
Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance
Florence Brossier, Nicolas Veziris, Chantal Truffot-Pernot, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 11, 2009
Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis
Murad Ibrahim, Chantal Truffot-Pernot, Koen Andries, et al.
BMC Infectious Diseases
|
January 14, 2014
Rifampicin mono-resistant tuberculosis in France: a 2005-2010 retrospective cohort analysis
Vanina Meyssonnier, Thuy Van Bui, Nicolas Veziris, et al.
The Journal of Antimicrobial Chemotherapy
|
September 9, 2016
In vivo Mycobacterium tuberculosis fluoroquinolone resistance emergence: a complex phenomenon poorly detected by current diagnostic tests
Christine Bernard, Alexandra Aubry, Aurélie Chauffour, et al.
Plos Neglected Tropical Diseases
|
September 1, 2020
Telacebec (Q203)-containing intermittent oral regimens sterilized mice infected with Mycobacterium ulcerans after only 16 doses
Aurélie Chauffour, Jérôme Robert, Nicolas Veziris, et al.
BMC Infectious Diseases
|
November 18, 2021
Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study
Nicolas Veziris, Claire Andréjak, Stéphane Bouée, et al.
Plos Neglected Tropical Diseases
|
November 27, 2023
Minimal effective dose of bedaquiline administered orally and activity of a long acting formulation of bedaquiline in the murine model of leprosy
Aurélie Chauffour, Nacer Lounis, Koen Andries, et al.
Journal of Clinical Microbiology
|
July 10, 2015
Characterization of a Clone of Mycobacterium tuberculosis Clinical Isolates with Mutations in KatG (A110V), EthA (Q269STOP), and the inhA Promoter (-15C→T)
Florence Brossier, Christophe Sola, Christine Bernard, et al.
Journal of Clinical Microbiology
|
October 3, 2014
Significant difference in drug susceptibility distribution between Mycobacterium avium and Mycobacterium intracellulare
Aurélie Renvoisé, Christine Bernard, Nicolas Veziris, et al.
Page
of 12